1. HOME
  2. ABOUT US
    About Laekna Core Management Team Board of Directors Milestones Scientific Advisory Board Core Inverstors Honors & Awards
  3. R&D
    R&D Therapeutic Areas Candidates Pipeline Clinical Trials
  4. PARTNERSHIPS
    Strategic Partners Business Development Holistic Approach BD Contact
  5. INVESTORS
    Corporate Governance Financial Results Announcements and Circulars IR Calendar Listing Documents
  6. NEWS
    Press Releases Media Coverage
  7. CAREERS
    Global Team Career Development Jobs My Laekna
  8. CONTACT US
    Contact Us Leave Message
  9. RSS Feeds
CAREERS
OUR PEOPLE

Scroll down to see more

当前位置： HOME > Announcements and Circulars >

正文

[VOLUNTARY ANNOUNCEMENT] - INVESTIGATIONAL NEW DRUG APPROVAL FOR LAE102 FOR THE TREATMENT OF OBESITY WAS OBTAINED FROM THE CENTRE FOR DRUG EVALUATION OF THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA

Last:[Share Scheme] - PROPOSED ADOPTION OF THE SHARE AWARD SCHEME
Next:[Monthly Returns] - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
Back
Position Liaison

Email:hr@laekna.com

Contact Us

Popular recommendations

RSS Feeds
If you want to know more about Laekna, please fill in the form below and sign up for emails:
  1. Name*
  2. Email*
  3. Company
  4. Occupation

News

Positions

Follow us on Linkedin

  1. HOME
  2. ABOUT US
  3. R&D
  4. PARTNERSHIPS
  5. INVESTORS
  6. INVESTORS
  7. NEWS
  8. CAREERS

Copyright © Laekna Therapeutics, All Rights Reserved.  Privacy Policy

Follow us on Linkedin

Follow us on Wechat